The mechanisms of the neurotropic action of bromantan
Animal research · 1999
- What was studied
- Animal experiments and synaptosomal assays
- Main finding
- Experimental work examined dopamine, serotonin, and noradrenergic responses. These are mechanistic observations, not evidence of human cognitive or sleep benefits.
Rat neuroleptic antagonism · At 5 mg/kg
Reported findings and study design
Animal neurochemical and in-vitro synaptosome experiments.
Population or model Animal experiments and synaptosomal assays
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Rat neuroleptic antagonism | At 5 mg/kg | |
| Dopamine/serotonin uptake block | At 50 microM | |
| Norepinephrine uptake block | Above 500 microM | |
| Mouse serotonergic behavioral effects | 1–20 mg/kg | |
| Cat neuromuscular transmission | No effect at 1–50 mg/kg IV | |
| Central cholinergic effects | Inhibition described at 30–600 mg/kg |
Different species, routes and assay concentrations are not combined into a human potency estimate.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Species, assays, and exposures differ from everyday human use.
- A neurotransmitter-related signal does not establish a clinical mechanism or long-term safety.
Source details
PubMed record and English abstract checked.
Sources checked
Citation
Author affiliations · Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow
I. S. Morozov, G. S. Pukhova, N. A. Avdulov, S. A. Sergeeva, A. A. Spasov, I. N. Iezhitsa. The mechanisms of the neurotropic action of bromantan Eksp Klin Farmakol. 62(1):11–14